Assessment of Pulmonary Manifestations and Its Correlation with DLCO and Spirometry in Patients with Rheumatoid Arthritis
International Journal of Current Pharmaceutical Review and Research · 30.07.2026 · 18 (07)
DOI: 10.25258/ijcpr.18.7.87 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 30.07.2026. Verfasst von Shivani Chauhan und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Rheumatoid arthritis is a chronic systemic autoimmune disease that primarily affects the joints but may also involve extra-articular organs, especially the lungs. Pulmonary involvement in rheumatoid arthritis may remain asymptomatic in the early stage and can present with restrictive, obstructive, or mixed ventilatory defects. Spirometry and diffusing capacity of the lung for carbon monoxide (DLCO) are important pulmonary function tests for detecting respiratory impairment and assessing subclinical lung involvement.
Aim
The aim of the study was to assess pulmonary manifestations and their correlation with DLCO and spirometry in patients with rheumatoid arthritis. Material and Methods: This single-centre, hospital-based, cross-sectional study was conducted in the Outpatient Department of Respiratory Medicine and Rheumatology Department at People’s Hospital, Bhopal. A total of 54 patients with clinically and/or serologically confirmed rheumatoid arthritis were included as per inclusion and exclusion criteria. After obtaining written informed consent, demographic details, clinical history, respiratory symptoms, and relevant examination findings were recorded. All participants underwent routine investigations, rheumatoid factor assessment, chest X-ray, spirometry, and DLCO testing. Disease activity was assessed using the Clinical Disease Activity Index and Simplified Disease Activity Index. Data were analysed to determine pulmonary manifestations and their correlation with spirometry and DLCO findings.
Results
Among 54 participants, the majority were in the 41–50 years age group, 22 (40.7%), and females predominated, 41 (75.9%). Respiratory symptoms were absent in 28 (51.85%) patients, while dyspnea was the most common symptom, seen in 14 (25.67%). Chest X-ray was normal in 36 (66.67%) patients. Spirometry was abnormal in 26 (48.15%) patients, with restrictive pattern being the most common abnormality, 16 (29.63%). DLCO was reduced in 34 (62.96%) patients. Both spirometry and DLCO were abnormal in 22 (40.74%) cases, while isolated DLCO abnormality was seen in 12 (22.22%). Significant correlation was observed between pulmonary function abnormalities and disease activity assessed by CDAI and SDAI.
Conclusion
Pulmonary involvement was common in rheumatoid arthritis patients, with interstitial lung disease being the most frequent manifestation. DLCO detected more abnormalities than spirometry and may help in early identification of subclinical pulmonary involvement.
Zitieren
APA
Chauhan, S., Shrikhande, A., Sahu, R., & Thakur, A. (2026). Assessment of Pulmonary Manifestations and Its Correlation with DLCO and Spirometry in Patients with Rheumatoid Arthritis. International Journal of Current Pharmaceutical Review and Research, 18(07). https://doi.org/10.25258/ijcpr.18.7.87
Vancouver
Chauhan S, Shrikhande A, Sahu R, Thakur A. Assessment of Pulmonary Manifestations and Its Correlation with DLCO and Spirometry in Patients with Rheumatoid Arthritis. International Journal of Current Pharmaceutical Review and Research. 2026;18(07). doi:10.25258/ijcpr.18.7.87
BibTeX
@article{Chauhan2026,
author = {Chauhan, Shivani and Shrikhande, Akash and Sahu, Rahul and Thakur, Arihant},
title = {Assessment of Pulmonary Manifestations and Its Correlation with DLCO and Spirometry in Patients with Rheumatoid Arthritis},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {07},
doi = {10.25258/ijcpr.18.7.87}
}
EUVIMED